GoKawiilNew model reframes Alzheimer's as staged inflection points, not linear cascade
Researchers propose that Alzheimer's disease progresses through distinct molecular and cellular phases marked by biological thresholds, rather than a simple straight-line path from amyloid buildup to Tau pathology to neurodegeneration. At these thresholds, cells lose homeostatic balance and shift behavior, with these altered states spreading unevenly across brain tissue and eventually reaching regions critical to cognition. A key threshold identified is when amyloid triggers Tau phosphorylation, marking the transition from amyloid-driven tissue states to ones dominated by neuronal stress responses.
GoKawiil's interpretation of the reporting above, not reported fact.
This framework could explain why the severity of brain pathology doesn't always match symptom severity in patients, a long-standing puzzle in Alzheimer's research. It also offers a unified explanation for both inherited and sporadic forms of the disease, potentially guiding new therapeutic strategies that target specific thresholds or transition points rather than treating the disease as one continuous process.
- Alzheimer's may progress through distinct threshold-based phases rather than a single linear pathological cascade.
- Amyloid-triggered Tau phosphorylation represents a critical inflection point separating disease stages.
- The model helps explain mismatches between pathology severity and symptoms, and links familial and sporadic disease forms.
Source: nature.com — De Strooper, 2026-09-16
Published there as: “Inflection points and transitions in Alzheimer’s disease”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.